ロード中...
Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China
Background To determine the efficacy of low-dose, immediate-release tacrolimus in patients with myasthenia gravis (MG) with inadequate response to glucocorticoid therapy in a randomized, double-blind, placebo-controlled study. Methods Eligible patients had inadequate response to glucocorticoids (GCs...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2017-09-01
|
| シリーズ: | Therapeutic Advances in Neurological Disorders |
| オンライン･アクセス: | https://doi.org/10.1177/1756285617721092 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|